Xirmada Baadhista ee Fayraska Isku-dhafan ee Antigen ilaa Neefsashada ee Colloidal Gold
Xirmada Baadhista ee Fayraska Isku-dhafka ah ee Antigen ilaa Neefsashada
Dahabka Kolloidal
Macluumaadka wax soo saarka
| Lambarka Moodeelka | RSV-AG | Baakad | 25 Tijaabo/xirmo, 30 xirmo/CTN |
| Magaca | Xirmada Baadhista ee Fayraska Isku-dhafka ah ee Antigen ilaa Neefsashada Dahabka Kolloidal | Kala soocidda qalabka | Fasalka 1aad |
| Astaamaha | Xasaasiyadda Sare, Hawlgal Fudud | Shahaadada | CE/ ISO13485 |
| Saxnaanta | > 99% | Muddada khaanadaha | Laba Sano |
| Habka cilmi-baarista | Dahabka Kolloidal | Adeegga OEM/ODM | La heli karo |
Habka tijaabada
| 1 | Qalabka tijaabada ka soo saar bacda aluminiumka ah, saar miis siman oo si sax ah u calaamadee muunadda. |
| 2 | Ku dar 10 uL oo muunad seeram ama balaasma ah ama 20 uL oo dhiig ah oo dhan godka muunadda, ka dibna Dhibic 100uL (qiyaastii 2-3 dhibcood) oo ah dareeraha muunadda ah ee lagu qaso godka muunadda iyo waqtiga bilowga. |
| 3 | Natiijada waa in la akhriyaa 10-15 daqiiqo gudahood. Natiijada baaritaanka waxay noqon doontaa mid aan sax ahayn 15 daqiiqo ka dib. |
Fiiro gaar ah: muunad kasta waa in lagu shubaa tuubooyin nadiif ah oo la tuuri karo si looga fogaado wasakhowga isdhaafka ah.
Ujeeddo Isticmaal
Reagent-kan waxaa loo isticmaalaa in lagu ogaado tayada antigen-ka fayraska isku-xidhka neefsashada (RSV) ee shaybaarada suufka afka iyo sanka, waana ku habboon yahay ogaanshaha kaalmaynta ee caabuqa fayraska isku-xidhka neefsashada. Xirmadan waxay bixisaa oo keliya natiijada ogaanshaha antigen-ka fayraska isku-xidhka neefsashada, natiijooyinka la helayna waa in lagu daraa macluumaadka kale ee caafimaad si loo falanqeeyo. Waa inay isticmaalaan oo keliya xirfadlayaasha daryeelka caafimaadka.
Soo Koobid
Fayraska isku-xidhka neefsashada waa fayras RNA ah oo ka tirsan hidde-sidaha Pneumovirus, oo ah qoyska Pneumovirinae. Inta badan wuxuu ku faafaa gudbinta dhibcaha, taabashada tooska ah ee faraha oo ay wasakheeyeen fayraska isku-xidhka neefsashada oo ay weheliso xuubka sanka iyo xuubka indhaha ayaa sidoo kale ah waddo muhiim ah oo lagu gudbiyo. Fayraska isku-xidhka neefsashada ayaa sababa oof-wareen. Marka la bilaabo xilliga uu cudurku ku dhaco, fayraska isku-xidhka neefsashada wuxuu sababi doonaa qandho, san duuf, qufac iyo mararka qaarkood neefta oo ku qabata. Caabuqa fayraska isku-xidhka neefsashada ayaa laga yaabaa inuu ka dhex dhaco dadka da' kasta leh, halkaas oo dadka waayeelka ah iyo dadka qaba sambabada, wadnaha ama habdhiska difaaca jirka oo daciif ah ay u badan tahay inay qaadaan cudurka.
Sifo:
• Xasaasi sare
• natiijada akhrinta 15 daqiiqo gudahood
• Hawlgal fudud
• Qiimaha tooska ah ee warshadda
• Uma baahnid mashiin dheeraad ah si aad natiijooyinka u akhrido
Akhrinta natiijada
Tijaabada falgalka WIZ BIOTECH waxaa la barbar dhigi doonaa falgalka xakamaynta:
| Natiijada tijaabada ee wiz | Natiijada tijaabada ee reagents-ka tixraaca | Heerka isku-soo-dhowaanshaha togan:74.03%(95%CI67.19%~79.87%)Heerka isku beegsiga taban: 99.22%(95%CI97.73%~99.73%)Heerka guud ee u hoggaansanaanta:99.29%(95%CI88.52%~93.22%) | ||
| Togan | Taban | Wadarta | ||
| Togan | 134 | 3 | 137 | |
| Taban | 47 | 381 | 428 | |
| Wadarta | 181 | 384 | 565 | |
Akhrinta natiijada
Tijaabada falgalka WIZ BIOTECH waxaa la barbar dhigi doonaa falgalka xakamaynta:
| Natiijada tijaabada ee wiz | Natiijada tijaabada ee reagents-ka tixraaca | Heerka isku-soo-dhowaanshaha togan:74.03%(95%CI67.19%~79.87%)Heerka isku beegsiga taban: 99.22%(95%CI97.73%~99.73%)Heerka guud ee u hoggaansanaanta:99.29%(95%CI88.52%~93.22%) | ||
| Togan | Taban | Wadarta | ||
| Togan | 134 | 3 | 137 | |
| Taban | 47 | 381 | 428 | |
| Wadarta | 181 | 384 | 565 | |
Waxa kale oo aad jeclaan kartaa:














